Replication data for a 2023 study published in the journal Cells. The research investigated the cardiovascular protective effects of the drug NP-6A4 in female rat models with obesity and pre-diabetes. The dataset was authored by Hao Wei Chen and originates from the PMC10216951 organization.
Use Cases
- Validate drug efficacy findings for NP-6A4 based on cardiovascular and metabolic outcome measures mentioned in the description
- Analyze sex-specific treatment responses based on the use of female rodent models described
- Compare preclinical results for pediatric cardiomyopathy drug candidates based on the FDA designation mentioned
- Investigate the relationship between obesity, pre-diabetes, and cardiovascular health based on the described animal model
Strengths
- Data supports a peer-reviewed study published in the journal Cells in 2023
- Focuses on a drug with FDA designation for pediatric cardiomyopathy
- Uses a specific preclinical model of female rats with obesity and pre-diabetes
Limitations
- Column-level documentation is absent; field semantics must be inferred after download
- Row count is unknown, which may limit suitability assessment
- Description metadata is limited; actual data quality requires manual inspection after download
Provenance
- Source
- PMC10216951 organization
- Collection Method
- Likely contains experimental measurements from a preclinical animal study.
- Freshness
- Last updated 2026-06-18 10:36:10; freshness should be verified